Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude osteoarthritis patients with a risk of joint collapse, but it was still not enough!

IF 7.2 2区医学 Q1 ORTHOPEDICS

Osteoarthritis and Cartilage Pub Date : 2024-09-03 DOI:10.1016/j.joca.2024.08.011

Ali Guermazi

引用次数: 0

查看原文本刊更多论文

关于神经生长因子（NGF）抑制剂的两项研究实施了严格的缓解计划，以排除有关节塌陷风险的 OA 患者，但这仍然不够！

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Osteoarthritis and Cartilage 医学-风湿病学

CiteScore

11.70

自引率

7.10%

发文量

802

审稿时长

52 days

期刊介绍： Osteoarthritis and Cartilage is the official journal of the Osteoarthritis Research Society International. It is an international, multidisciplinary journal that disseminates information for the many kinds of specialists and practitioners concerned with osteoarthritis.